Lance E. Thibault - May 16, 2023 Form 3 Insider Report for Finch Therapeutics Group, Inc. (FNCH)

Signature
/s/ Matthew P. Blischak, Attorney-in-Fact
Stock symbol
FNCH
Transactions as of
May 16, 2023
Transactions value $
$0
Form type
3
Date filed
5/16/2023, 04:05 PM
Previous filing
Feb 3, 2022

No securities are beneficially owned.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney